ABBOTT LABORATORIES — Director's Dealing 2004

Apr 2, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-03-31

Reporting Person: LIEPMANN HOLGER A (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-03-31	Common shares without par value	A	3500	—	Acquired	64912	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-03-31	Option (right to buy)	$41.10	A	25000	Acquired	2014-03-30	common shares (25000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	12633	Indirect
Common shares without par value	295	Indirect
Common shares without par value	296	Indirect

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2004.

F3: Reporting person disclaims beneficial ownership of shares held by his daughters.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 8,334 on 3/31/05, 8,333 on 3/31/06 and 8,333 on 3/31/07.